• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Acute rejection and coronary artery disease in long-term survivors of heart transplantation.

作者信息

Narrod J, Kormos R, Armitage J, Hardesty R, Ladowski J, Griffith B

机构信息

University of Pittsburgh School of Medicine, Pennsylvania.

出版信息

J Heart Transplant. 1989 Sep-Oct;8(5):418-20; discussion 420-1.

PMID:2795285
Abstract

The development of acute rejection and coronary artery disease (CAD) was studied in 173 patients who survived at least 1 year after orthotopic heart transplantation. There were 20 late deaths. The incidence of acute rejection found on endomyocardial biopsies after 1 year was 5.6%. Alteration in the immunosuppressive regimen accounted for 77% of the rejection episodes (chi-square = 9.3, F less than 0.01). Acute rejection without alteration in immunosuppressive therapy occurred only 1.4% of the time. CAD developed in 28 patients (16.2%). The prevalence of CAD was 5.8% at 1 year, 15.5% at 2 years, and increased to 66% at 6 years. Patients developing CAD had 0.5 (+/- 0.8) rejection episodes after 1 year as opposed to 0.2 (+/- 0.5) rejection episodes in patients with no CAD (S1 less than 0.01 by Mann-Whitney). There was no difference in the number of rejection episodes during the first year. The total number of rejection episodes was 1.9 (+/- 1.6) and 1.2 (+/- 1.2) in patients with and without CAD, respectively (S1 less than 0.03 by Mann-Whitney). Diabetes mellitus was present in 25% of patients with CAD and 16.5% of patients without CAD (chi-square = 3.14, F less than 0.1). Acute rejection rarely occurs after 1 year and is usually caused by an alteration in the immunosuppressive regimen. CAD develops with increasing frequency and is correlated with rejection episodes and diabetes mellitus.

摘要

相似文献

1
Acute rejection and coronary artery disease in long-term survivors of heart transplantation.
J Heart Transplant. 1989 Sep-Oct;8(5):418-20; discussion 420-1.
2
Predictors of late acute orthotopic heart transplant rejection.晚期急性原位心脏移植排斥反应的预测因素。
Circulation. 1989 Nov;80(5 Pt 2):III106-10.
3
Coronary artery disease in cardiac transplant patients receiving triple-drug immunosuppressive therapy.
Circulation. 1989 Nov;80(5 Pt 2):III111-5.
4
Survival, graft atherosclerosis, and rejection incidence in heart transplant recipients treated with statins: 5-year follow-up.接受他汀类药物治疗的心脏移植受者的生存率、移植血管动脉粥样硬化及排斥反应发生率:5年随访
J Heart Lung Transplant. 2005 Sep;24(9):1235-8. doi: 10.1016/j.healun.2004.08.014.
5
Ten- and 20-year survivors of pediatric orthotopic heart transplantation.小儿原位心脏移植的10年和20年幸存者。
J Heart Lung Transplant. 2006 Mar;25(3):261-70. doi: 10.1016/j.healun.2005.09.011. Epub 2006 Jan 6.
6
The prognostic impact of immunosuppression and cellular rejection on cardiac allograft vasculopathy: time for a reappraisal.免疫抑制和细胞性排斥反应对心脏移植血管病变的预后影响:是时候重新评估了。
J Heart Lung Transplant. 1997 Jul;16(7):743-51.
7
FK506 effectiveness in reducing acute rejection after heart transplantation: a prospective randomized study.FK506在降低心脏移植后急性排斥反应中的有效性:一项前瞻性随机研究。
J Heart Lung Transplant. 1997 Oct;16(10):1001-10.
8
Timing of the first endomyocardial biopsy in heart transplantation after induction immunosuppressive therapy--experience from Canadian Heart Transplant Centre.诱导免疫抑制治疗后心脏移植首次心内膜心肌活检的时机——来自加拿大心脏移植中心的经验
Cas Lek Cesk. 2005;144(8):507-9; discussion 509.
9
Influence of graft rejection on incidence of accelerated graft coronary artery disease: a new approach to analysis.
J Heart Lung Transplant. 1993 Nov-Dec;12(6 Pt 1):1029-35.
10
Reversal of rejection-induced coronary vasculitis detected early after heart transplantation with increased immunosuppression.心脏移植术后早期检测到的排斥反应所致冠状动脉血管炎通过增加免疫抑制得以逆转。
J Heart Transplant. 1989 Sep-Oct;8(5):413-7.

引用本文的文献

1
The Man with 2 Hearts: 25 Years from Heterotopic to Orthotopic Heart Transplantation.拥有两颗心脏的人:从异位心脏移植到原位心脏移植的25年历程
Tex Heart Inst J. 2019 Jun 1;46(3):199-202. doi: 10.14503/THIJ-17-6544. eCollection 2019 Jun.
2
Combined heart and liver transplant attenuates cardiac allograft vasculopathy compared with isolated heart transplantation.心脏和肝脏联合移植与单独心脏移植相比,可减轻心脏移植后血管病变。
Transplantation. 2013 Mar 27;95(6):859-65. doi: 10.1097/TP.0b013e31827eef7e.
3
Perforin mediates endothelial cell death and resultant transplant vascular disease in cardiac allografts.
穿孔素介导心脏同种异体移植中内皮细胞死亡及由此导致的移植血管病。
Am J Pathol. 2004 Jul;165(1):127-33. doi: 10.1016/S0002-9440(10)63281-6.
4
The development of transplant coronary artery disease after cardiac transplantation is correlated with a predominance of CD8+ T lymphocytes in endomyocardial biopsy derived T cell cultures.心脏移植后移植冠状动脉疾病的发展与心内膜心肌活检来源的T细胞培养物中CD8 + T淋巴细胞占优势相关。
Clin Exp Immunol. 1994 Oct;98(1):158-62. doi: 10.1111/j.1365-2249.1994.tb06623.x.
5
VLA-4 and lymphocyte trafficking in immune-inflammatory states: novel therapeutic approaches in allograft arteriopathy.VLA - 4与免疫炎症状态下的淋巴细胞迁移:同种异体移植血管病的新型治疗方法
Springer Semin Immunopathol. 1995;16(4):443-65. doi: 10.1007/BF00196100.
6
Modification of alternative messenger RNA splicing of fibroblast growth factor receptors in human cardiac allografts during rejection.人心脏同种异体移植排斥反应期间成纤维细胞生长因子受体的可变信使核糖核酸剪接修饰
J Clin Invest. 1994 Sep;94(3):992-1003. doi: 10.1172/JCI117466.
7
Impairment of coronary flow reserve in orthotopic cardiac transplant recipients with minor coronary occlusive disease.轻度冠状动脉闭塞性疾病的原位心脏移植受者的冠状动脉血流储备受损。
Br Heart J. 1992 Sep;68(3):266-71. doi: 10.1136/hrt.68.9.266.
8
Coronary occlusive disease and late graft failure after cardiac transplantation.心脏移植后的冠状动脉闭塞性疾病和晚期移植物功能衰竭。
Br Heart J. 1992 Sep;68(3):260-5. doi: 10.1136/hrt.68.9.260.
9
Coronary artery disease after heart transplantation: clinical aspects.心脏移植后的冠状动脉疾病:临床方面
Br Heart J. 1992 Sep;68(3):255-6. doi: 10.1136/hrt.68.9.255.